{"id":"https://openalex.org/W7148969547","doi":"https://doi.org/10.1158/1538-7445.am2026-7064","title":"Abstract 7064: Development of a new class of KAT6A/B inhibitors with in vivo efficacy.","display_name":"Abstract 7064: Development of a new class of KAT6A/B inhibitors with in vivo efficacy.","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148969547","doi":"https://doi.org/10.1158/1538-7445.am2026-7064"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-7064","doi":"https://doi.org/10.1158/1538-7445.am2026-7064","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-7064","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038269097","display_name":"Antonius ter Laak","orcid":"https://orcid.org/0000-0003-1820-002X","observed_orcids":["https://orcid.org/0000-0003-1820-002X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Antonius ter Laak","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054997015","display_name":"Roman Christian Hillig","orcid":"https://orcid.org/0000-0001-6267-7250","observed_orcids":["https://orcid.org/0000-0001-6267-7250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roman Hillig","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051824746","display_name":"Steven J. Ferrara","orcid":"https://orcid.org/0009-0009-8275-2321","observed_orcids":["https://orcid.org/0009-0009-8275-2321"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Ferrara","raw_affiliation_strings":["3Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, Boston, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091637701","display_name":"Daniel Korr","orcid":"https://orcid.org/0000-0002-6250-6344","observed_orcids":["https://orcid.org/0000-0002-6250-6344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Korr","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019808915","display_name":"Peter Staller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Staller","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023352166","display_name":"Naomi N. Barak","orcid":"https://orcid.org/0000-0002-8166-9616","observed_orcids":["https://orcid.org/0000-0002-8166-9616"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Naomi Barak","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084853335","display_name":"Philip Lienau","orcid":"https://orcid.org/0000-0002-6048-4559","observed_orcids":["https://orcid.org/0000-0002-6048-4559"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philip Lienau","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030450474","display_name":"Simon A. Herbert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Simon Herbert","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132836258","display_name":"Amaury Fernandez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Amaury Fernandez","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032703270","display_name":"Roland Neuhaus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roland Neuhaus","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067338320","display_name":"M\u00e1ty\u00e1s Gorj\u00e1n\u00e1cz","orcid":"https://orcid.org/0000-0002-8398-410X","observed_orcids":["https://orcid.org/0000-0002-8398-410X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matyas Gorjanacz","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036690578","display_name":"Vera Puetter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vera Puetter","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024172426","display_name":"Volker Badock","orcid":"https://orcid.org/0000-0002-5437-3916","observed_orcids":["https://orcid.org/0000-0002-5437-3916"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Volker Badock","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027786333","display_name":"Wilhelm Bone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wilhelm Bone","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057470948","display_name":"Craig A. Strathdee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig Strathdee","raw_affiliation_strings":["3Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, Boston, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055135489","display_name":"Franziska Siegel","orcid":"https://orcid.org/0009-0002-8685-2142","observed_orcids":["https://orcid.org/0009-0002-8685-2142"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Franziska Siegel","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044317425","display_name":"Christoph Schatz","orcid":"https://orcid.org/0000-0001-8017-3400","observed_orcids":["https://orcid.org/0000-0001-8017-3400"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Schatz","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021012893","display_name":"Katrin Nowak\u2010Reppel","orcid":"https://orcid.org/0000-0003-4029-099X","observed_orcids":["https://orcid.org/0000-0003-4029-099X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nowak-Reppel Katrin","raw_affiliation_strings":["2Nuvisan ICB GmbH, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Nuvisan ICB GmbH, Berlin, Germany;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091614834","display_name":"Olaf Doehr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Olaf Doehr","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005190013","display_name":"Stefan Gradl","orcid":"https://orcid.org/0000-0002-7728-1192","observed_orcids":["https://orcid.org/0000-0002-7728-1192"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefan Gradl","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000161986","display_name":"Ingo Volker Hartung","orcid":"https://orcid.org/0000-0001-8750-679X","observed_orcids":["https://orcid.org/0000-0001-8750-679X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ingo Hartung","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056373767","display_name":"Matthew M. Meyerson","orcid":"https://orcid.org/0000-0002-9133-8108","observed_orcids":["https://orcid.org/0000-0002-9133-8108"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Meyerson","raw_affiliation_strings":["3Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Broad Institute of MIT and Harvard, Center for the Development of Therapeutics, Boston, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024506546","display_name":"L\u00e9a Bouch\u00e9","orcid":"https://orcid.org/0000-0001-8523-812X","observed_orcids":["https://orcid.org/0000-0001-8523-812X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lea Bouche","raw_affiliation_strings":["1Bayer Pharma AG, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Pharma AG, Berlin, Germany;","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"7064","last_page":"7064"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.06840000301599503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10222","display_name":"Genomics and Chromatin Dynamics","score":0.02370000071823597,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kat6a","display_name":"KAT6A","score":0.9629999995231628},{"id":"https://openalex.org/keywords/kat6b","display_name":"KAT6B","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/chromatin-modification","display_name":"chromatin modification","score":0.7260000109672546},{"id":"https://openalex.org/keywords/co-crystallization","display_name":"co-crystallization","score":0.7689999938011169},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5315999984741211},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5080999732017517},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.49480000138282776},{"id":"https://openalex.org/C66746571","wikidata":"https://www.wikidata.org/wiki/Q1134833","display_name":"ENCODE","level":3,"score":0.4717999994754791},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4560000002384186},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4546999931335449},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4180000126361847},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40540000796318054},{"id":"https://openalex.org/C2777212361","wikidata":"https://www.wikidata.org/wiki/Q5127848","display_name":"Class (philosophy)","level":2,"score":0.39399999380111694},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.3790000081062317},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.35249999165534973},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.33820000290870667},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3248000144958496},{"id":"https://openalex.org/C3018928802","wikidata":"https://www.wikidata.org/wiki/Q83185","display_name":"Gene transfer","level":3,"score":0.3230000138282776},{"id":"https://openalex.org/C7602840","wikidata":"https://www.wikidata.org/wiki/Q746284","display_name":"Gene duplication","level":3,"score":0.3061999976634979},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3050999939441681},{"id":"https://openalex.org/C2776016237","wikidata":"https://www.wikidata.org/wiki/Q178430","display_name":"Lysine","level":3,"score":0.30079999566078186},{"id":"https://openalex.org/C2910921701","wikidata":"https://www.wikidata.org/wiki/Q1036906","display_name":"Histone Acetyltransferases","level":4,"score":0.29089999198913574},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2842000126838684},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.27900001406669617},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.26809999346733093},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.2572999894618988}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-7064","doi":"https://doi.org/10.1158/1538-7445.am2026-7064","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-7064","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403767980","https://openalex.org/W4417026620","https://openalex.org/W4393095664","https://openalex.org/W4409690777","https://openalex.org/W7126059792","https://openalex.org/W3022640766","https://openalex.org/W4396591047","https://openalex.org/W7125378405","https://openalex.org/W4385650419","https://openalex.org/W2899175470"],"abstract_inverted_index":{"Abstract":[0],"KAT6A":[1,79],"and":[2,26,80,90,96],"KAT6B":[3],"encode":[4],"lysine":[5,17],"acetyltransferases":[6],"that":[7,73],"catalyse":[8],"the":[9,39,189],"transfer":[10],"of":[11,30,51,59,70,78,174,178,188],"acetyl":[12],"groups":[13],"from":[14,102],"acetyl-CoA":[15],"to":[16,56],"residues":[18],"on":[19],"histone":[20],"proteins,":[21],"thereby":[22],"influencing":[23],"chromatin":[24],"structure":[25],"gene":[27],"expression.":[28],"Amplification":[29],"these":[31],"genes":[32],"is":[33],"observed":[34],"in":[35,45,48,108,110,182],"several":[36],"cancers,":[37],"with":[38,181],"8p11-p12":[40],"chromosomal":[41],"region\u2014containing":[42],"KAT6A\u2014being":[43],"increased":[44],"copy":[46],"number":[47],"approximately":[49],"12-15%":[50],"breast":[52],"cancer":[53],"cases,":[54],"leading":[55],"higher":[57],"expression":[58],"chromatin-modifying":[60],"enzymes.":[61],"In":[62],"this":[63,103],"study,":[64],"we":[65],"introduce":[66],"a":[67,118,175],"novel":[68],"series":[69],"acylsulfonamide-benzofuran":[71],"compounds":[72],"function":[74],"as":[75,117],"selective":[76],"inhibitors":[77,83,180],"KAT6B.":[81],"These":[82],"were":[84],"first":[85],"identified":[86],"via":[87],"high-throughput":[88],"screening":[89],"subsequently":[91],"refined":[92],"through":[93],"computational":[94],"modelling":[95],"co-crystallization":[97],"studies.":[98],"The":[99],"lead":[100],"compound":[101],"series,":[104],"BAY-184,":[105],"demonstrated":[106],"efficacy":[107,184],"an":[109],"vivo":[111,183],"proof-of-concept":[112],"experiment,":[113],"confirming":[114],"its":[115],"potential":[116],"tool":[119],"for":[120,192],"targeting":[121],"KAT6A/B":[122,179],"activity.":[123],"Citation":[124],"Format:":[125],"Antonius":[126],"ter":[127],"Laak,":[128],"Roman":[129],"Hillig,":[130],"Steven":[131],"Ferrara,":[132],"Daniel":[133],"Korr,":[134],"Peter":[135],"Staller,":[136],"Naomi":[137],"Barak,":[138],"Philip":[139],"Lienau,":[140],"Simon":[141],"Herbert,":[142],"Amaury":[143],"Fernandez,":[144],"Roland":[145],"Neuhaus,":[146],"Matyas":[147],"Gorjanacz,":[148],"Vera":[149],"Puetter,":[150],"Volker":[151],"Badock,":[152],"Wilhelm":[153],"Bone,":[154],"Craig":[155],"Strathdee,":[156],"Franziska":[157],"Siegel,":[158],"Christoph":[159],"Schatz,":[160],"Nowak-Reppel":[161],"Katrin,":[162],"Olaf":[163],"Doehr,":[164],"Stefan":[165],"Gradl,":[166],"Ingo":[167],"Hartung,":[168],"Matthew":[169],"Meyerson,":[170],"Lea":[171],"Bouche.":[172],"Development":[173],"new":[176],"class":[177],"[abstract].":[185],"In:":[186],"Proceedings":[187],"American":[190],"Association":[191],"Cancer":[193,211],"Research":[194],"Annual":[195],"Meeting":[196],"2026;":[197],"Part":[198],"1":[199],"(Regular":[200],"Abstracts);":[201],"2026":[202],"Apr":[203],"17-22;":[204],"San":[205],"Diego,":[206],"CA.":[207],"Philadelphia":[208],"(PA):":[209],"AACR;":[210],"Res":[212],"2026;86(7":[213],"Suppl):Abstract":[214],"nr":[215],"7064.":[216]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2026-04-04T00:00:00"}